NM_206933.4(USH2A):c.13984C>G (p.Gln4662Glu) AND not provided
- Germline classification:
- Benign (3 submissions)
- Last evaluated:
- Jan 31, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000828964.11
Allele description [Variation Report for NM_206933.4(USH2A):c.13984C>G (p.Gln4662Glu)]
NM_206933.4(USH2A):c.13984C>G (p.Gln4662Glu)
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
hypothetical protein mlr6684 [Mesorhizobium loti MAFF303099]
hypothetical protein mlr6684 [Mesorhizobium loti MAFF303099]gi|13475578|ref|NP_107142.1|Protein
-
Homo sapiens lysyl oxidase-like 3 (LOXL3), mRNA
Homo sapiens lysyl oxidase-like 3 (LOXL3), mRNAgi|14211942|ref|NM_032603.1|Nucleotide
-
alpha-1A adrenergic receptor isoform 2 [Homo sapiens]
alpha-1A adrenergic receptor isoform 2 [Homo sapiens]gi|111118986|ref|NP_150646.3|Protein
-
Homo sapiens elaC homolog 2 (E. coli) (ELAC2), mRNA
Homo sapiens elaC homolog 2 (E. coli) (ELAC2), mRNAgi|21359940|ref|NM_018127.3|Nucleotide
-
Homo sapiens putative prostate cancer susceptibility protein (HPC2), mRNA
Homo sapiens putative prostate cancer susceptibility protein (HPC2), mRNAgi|8922493|ref|NM_018127.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 7, 2024